Behrakis To Be Honored

George D. Behrakis

George D. Behrakis, a life-time Chairman Emeritus of Leadership 100, will be the honoree at the 18th annual gala of The Hellenic Times Scholarship Fund on May 16, receiving the Humanitarian Leadership Award.
Behrakis, who served as Chairman of Leadership 100 from 2006 to 2008, was designated a life-time Chairman Emeritus of the 25-year-old organization joining his predecessor as Chairman, John A. Payiavlas and the five life-time Founders, Andrew A. Athens, Arthur C. Anton, George K. Chimples, Peter M. Dion and Michael Jaharis. Payiavlas and Behrakis replaced two of the deceased founders, George P. Kokalis and Thomas A. Athens.

Recognized as a leader in the pharmaceutical field, Behrakis began his career at McNeil Laboratories, a division of Johnson & Johnson. He founded Dooner Laboratories, later sold to Rhone-Poulenc Rorer, and purchased Muro Pharmaceuticals in 1978, which was sold to ASTA Medica AG of Frankfurt, Germany in 1997. He retired as President/CEO of Muro in 1998.

A graduate of Northeastern University, he also studied at Boston University and has established numerous awards, chairs and facilities in the pharmaceutical, scientific and medical fields, at Northeastern, Tufts University, Boston College, Harvard University and The Johns Hopkins University.

The Hellenic Times Scholarship Fund, founded by John and Margo Catsimatidis with Nick Katsoris, has awarded over $1.5 million in scholarships to students from across the United States. The sole fundraiser for the organization is its annual Awards Gala in May. The funds for the Scholarships awarded are principally raised through the gala journal, raffle and the generosity of members of the community and corporations who purchase tables and make donations. According to the organization, every cent raised after event expenses and operating expenses goes directly to scholarships for the education of students.
L100 Links
The Archbishop Iakovos Leadership 100 Fund Incorporated. All Rights Reserved. | Privacy Statement | Terms Of Use | |